Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.
about
Emerging approaches in Parkinson's disease - adjunctive role of safinamideAdjuvant therapies for Parkinson's disease: critical evaluation of safinamidePharmacology and Clinical Drug Candidates in Redox MedicineNew treatments for the motor symptoms of Parkinson's disease.The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.Recent advances in treating Parkinson's disease.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLEPopulation pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease.Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis.Emerging drugs for levodopa-induced dyskinesia.Safinamide for the treatment of Parkinson's disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Safinamide: first global approval.Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Rational drug discovery design approaches for treating Parkinson's disease.Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.New treatments for levodopa-induced motor complications.Modern treatment in Parkinson's disease, a personal approach.Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease.New and emerging medical therapies in Parkinson's disease.Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.Nondopaminergic treatments for Parkinson's disease: current and future prospects.Safinamide: A Review in Parkinson's Disease.Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc Analysis.Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?Formulary Drug Review: Safinamide.Long-term Efficacy of Safinamide on Parkinson's Disease Chronic Pain.[Pharmacological treatment of motor symptoms in Parkinson's diseases].Safinamide: an add-on treatment for managing Parkinson's disease.Motor Complications of Dopaminergic Medications in Parkinson's Disease.Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence
P2860
Q26740905-5BC86EAF-CC6D-426A-9C60-F93794F15548Q26766289-A6A5EACE-5152-403A-B14F-1D53F46C8886Q26785525-1EDD27DA-32A9-4D02-8362-2BC47412194BQ34443682-BB672A20-8EA5-44ED-B476-5BA3A385A6CBQ34512544-3E1A646D-FBBF-468D-9F25-0A4987B0715DQ34554401-B8BC11BB-48D1-4EBF-BA2B-31025811115EQ36925905-6FB9F5F4-874E-4444-BEDF-487668576798Q37054010-02AF50E1-3F8E-4049-9F05-81B1F9F1A124Q37303004-F3380C81-9E72-41EC-ABB8-2F04E3DF8219Q37635600-6E0F5904-9D64-4E06-8029-9918747A05BBQ38242091-45DF1184-0525-4752-934F-6E470443C810Q38258514-794F6537-A9D2-4FA2-A555-7B4F4735FD17Q38262418-BA731A3F-07CF-4CA7-9609-1E5454E7462AQ38410199-17BA1ABF-2856-433C-83D0-9B2076DE56F9Q38476557-D1BB41E7-9603-4285-8949-E0D66A116712Q38478999-15381C25-C794-44CC-865B-694257FEEE1AQ38520864-975F2443-61AB-432E-A021-D59DD5464CDAQ38545359-2ECC96D0-C408-4C3E-99ED-9E25B685BCA6Q38570434-354E28E2-CDF1-4CB8-8315-6CF8B78FA0F4Q38570529-BAFF4510-8FDA-4D3A-B6B8-B0C7FB916522Q38640108-3F29446F-5BFD-4BE3-8B05-DD5A1B6C2BB1Q38640744-3F3C2DD1-1878-40A1-9E4E-C30FE4F41AFAQ38718194-FFE3323F-2806-43DC-A918-EB16A6ABC44CQ38817972-0F6569D7-7E9F-4E09-B1A8-73094C166E8BQ38845546-CA61FB49-A4BB-412A-9038-0B2A8D28EA8BQ39097789-0B2920B7-5472-4CF0-965A-86B3C3E171B4Q39325939-07EC39B8-A8CA-4E9C-ABEE-D05D48608732Q39350609-0338575F-978A-44B1-887E-31EA225134D7Q42531922-2B7B10EC-C992-4F74-B80B-C93DD01FD960Q47319471-5A93CA23-D093-4458-B98C-6121B1AADBA1Q47962428-DB26E6D8-E657-440A-9EFE-46A2D2DBDD5BQ48108548-ACE82D3A-83C5-48A4-8C3A-6984F51A02A8Q48250410-806B9AFE-AAB7-4F77-B974-C0E56C4142AEQ48345426-AEBF5A1B-A939-4528-8B7A-D206A75FA7FCQ49587005-67B9E119-9B00-483C-900B-EC4B71A68A67Q51739969-158B99FD-7228-4C2E-84BF-717D830FD255Q52703430-3A497F43-1A00-416F-911F-F4021F2FF304Q52804779-B714458C-C76B-453C-8DC4-0B2C7747703AQ55279095-3A43A8EA-5BD3-4270-A63A-A15D2A06DD75Q57074141-B605B0EA-C48C-46CF-8C4F-88BBB81E4F46
P2860
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Randomized trial of safinamide ...... sease with motor fluctuations.
@ast
Randomized trial of safinamide ...... sease with motor fluctuations.
@en
Randomized trial of safinamide ...... sease with motor fluctuations.
@nl
type
label
Randomized trial of safinamide ...... sease with motor fluctuations.
@ast
Randomized trial of safinamide ...... sease with motor fluctuations.
@en
Randomized trial of safinamide ...... sease with motor fluctuations.
@nl
prefLabel
Randomized trial of safinamide ...... sease with motor fluctuations.
@ast
Randomized trial of safinamide ...... sease with motor fluctuations.
@en
Randomized trial of safinamide ...... sease with motor fluctuations.
@nl
P2093
P2860
P356
P1433
P1476
Randomized trial of safinamide ...... sease with motor fluctuations.
@en
P2093
D Chirilineau
P Stanzione
R Giuliani
Rupam Borgohain
Study 016 Investigators
P2860
P304
P356
10.1002/MDS.25751
P407
P577
2013-12-09T00:00:00Z